Oral Communications

Monday 26/6

15.00-15.15: 72 – FoxA1 counteracts FoxP3 transcription factor to secure the FoxA1+ Treg cell fate
Louise Munk Rasmussen (University of Copenhagen, Denmark)

15.15.15.30: 83 – Protection against EAE by mannan-conjugated myelin peptides involves T cell anergy characterized by reduced antigen-specific proliferation and but not altered migration of T cells to the CNS
Anastasia Dagkonaki (Hellenic Pasteur Institute, Greece)

15.30-15.45: 100 – Inhibition of protein arginine deiminases reduces neuroinflammation and improves cognition in mouse models of Alzheimer’s disease
Enrica Pietronigro (University of Verona, Italy)

15.45-16.00: 97 – Understanding the role of age induced immune alterations in determining the worse outcome of stroke in the elderly
Giorgia Serena Gullotta (San Raffaele Scientific Institute, Italy)

17.15-17.30: 45 – Identification of RGS8 as an autoantibody target in paraneoplastic cerebellar syndrome
Ramona Miske (EUROIMMUN AG, Germany)

17.30-17.45: 8 – Screening for novel autoantigens in anti-GAD positive individuals
Iswariya Venkataraman (EUROIMMUN AG, Germany)

17.45-18.00: 34 – Molecular characterization of intrathecal antibody responses in anti-LGI1 encephalitis
Sumanta Barman (Universitaetsklinikum Duesseldorf, Germany)

18.00-18.15: 114 – CHROMOSOMALLY-INTEGRATED HHV-6 (ci HHV-6) POSSIBLE TRIGGER OF RELAPSING-REMITTING MULTIPLE SCLEROSIS?
Maria Teresa Ferrò (ASST Crema, Italy)

Tuesday 27/6

09.45-10.00: 16 – Protection against relapses of disease in a mouse model of multiple sclerosis by a parasite-derived 68-mer peptide
Aakanksha Dixit (University of Queensland, Australia)

10.00-10.15: 81 – High dose Vitamin D promotes experimental CNS autoimmune disease by raising T cell-excitatory calcium
Darius Haeusler (University Medical Center Goettingen, Germany)

10.15-10.30: 23 – Effects of intermittent fasting in experimental autoimmune encephalomyelitis and multiple sclerosis
Francesca Cignarella (Washington University in St. Louis, USA)

10.30-10.45: 96 – Orally administered propionic acid modulates immune cell balance and function in Multiple Sclerosis patients – a proof of concept study
Alexander Duscha (Ruhr-Universitaet Bochum, Germany)

12.00-12.15: 88 – Transcriptome profiling of brain lesion evolution in MS
ML Elkjaer (OUH/SDU, Denmark)

12.15-12.30: 128 – The potassium channel KCNK2 is a regulator of immune cell trafficking and inflammatory responses in idiopathic inflammatory myopathies
Thomas Muentefering (University of Muenster, Germany)

12.30-12.45: 84 – Dissecting the cellular and molecular requirements for TNF-mediated neuroprotection against glutamate excitotoxicity
Irini Papazian (Hellenic Pasteur Institute, Greece)

12.45-13.00: 17 – Brain immune response triggered by early developmental chronic consumption of methylphenidate: control vs attention- deficit/hyperactivity disorder rat model
Vanessa Coelho-Santos (University of Coimbra, Portugal)